Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study

References

• Salvinelli F, Firrisi L, Casale M, et al. What is vertigo? Clin Ther 2003;154:341–8
   Google Scholar
• Baloh RW. Vertigo. Lancet 1998;352:1841–6
   PubMed Web of Science ®Google Scholar
• Neuhauser HK, von Brevern M, Radtke A, et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005;65:898–904
   PubMed Web of Science ®Google Scholar
• Cioffi D. Beyond attentional strategies: a cognitive-perceptual model of somatic interpretation. Psychol Bull 1991;109:25–41
   PubMed Web of Science ®Google Scholar
• Soderman AC, Bagger-Sjoback D, Bergenius J, et al. Factors influencing quality of life in patients with Meniere’s disease, identified by a multidimensional approach. Otol Neurotol 2002;23:941–8
   PubMed Web of Science ®Google Scholar
• Pothula VB, Chew F, Lesser TH, et al. Falls and vestibular impairment. Clin Otolaryngol Allied Sci 2004;29:179–82
   PubMed Web of Science ®Google Scholar
• Yardley L, Todd C, Lacoudraye-Harter MM, et al. Psychosocial consequences of vertigo. Psychol Health 1992;6:85–96
   Google Scholar
• Monzani D, Casolari L, Guidetti G, et al. Psychological distress and disability in patients with vertigo. J Psychosom Res 2001;50:319–23
   PubMed Web of Science ®Google Scholar
• Monzani D, Genovese E, Rovatti V, et al. Life events and benign paroxysmal positional vertigo: a case-controlled study. Acta Otolaryngol 2006;126:987–92
   PubMed Web of Science ®Google Scholar
• Monzani D, Casolari L, Guidetti G, et al. Psychological distress and disability in patients with vertigo. J Psychosom Res 2001;50:319–23
   PubMed Web of Science ®Google Scholar
• Garcia FV, Coelho MH, Figueira ML. Psychological manifestations of vertigo: a pilot prospective observational study in a Portuguese population. Int Tinnitus J 2003;9:42–7
   Google Scholar
• Novotny M, Kostrica R. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Meniere’s disease: a randomized, double-blind, parallel group clinical study. Int Tinnitus J 2002;8:115–23
   PubMedGoogle Scholar
• Albera R, Ciuffolotti R, Di Cicco M, et al. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 2003;123:588–93
   PubMed Web of Science ®Google Scholar
• Mira E, Guidetti G, Ghilardi L, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003;260:73–7
   PubMed Web of Science ®Google Scholar
• Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 1990;116:424–7
   PubMed Web of Science ®Google Scholar
• Enloe LJ, Shields RK. Evaluation of health-related quality of life in individuals with vestibular disease using disease-specific and general outcome measures. Phys Ther 1997;77:890–903
   PubMed Web of Science ®Google Scholar
• Jarlsäter S, Mattson E. Test of reliability of the dizziness handicap inventory and the activities-specific balance confidence scale for use in Sweden. Adv Physiother 2003;5:137–44
   Google Scholar
• Kammerlind AS, Larssen PB, Ledin TE, et al. Reliability of clinical balance tests and subjective ratings in dizziness and disequilibrium. Adv Physiother 2005;7:96–107
   Google Scholar
• McHorney CA, Ware Jr JE, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66
   Google Scholar
• Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473–83
   Google Scholar
• McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–63
   Google Scholar
• Saris-Baglama RN, Dewey CJ, Chisholm GB, et al. SF Health Outcomes™ Scoring Software User’s Guide. Lincoln (RI), QualityMetrics Inc: 2004
   Google Scholar
• SF-36v2™. Scoring SF-36 scales. Lincoln (RI): QualityMetric Inc, 2000
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70
   PubMed Web of Science ®Google Scholar
• Snaith RP. The Hospital Anxiety and Depression scale. Health Qual Life Outcomes 2003;1:29
   PubMedGoogle Scholar
• Eaton T, Garrett JE, Young P, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J 2002;20:306–12
   PubMed Web of Science ®Google Scholar
• Grov EK, Dahl AA, Moum T, et al. Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol 2005;16:1185–91
   PubMed Web of Science ®Google Scholar
• Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2004;(2):CD003162
   Google Scholar
• Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, et al. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2005;262:507–11
   Google Scholar
• Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, et al. Impact of treatment on health-related quality of life in patients with posterior canal benign paroxysmal positional vertigo. Otol Neurotol 2003;24:637–41
   Google Scholar
• Handa PR, Kuhn AM, Cunha F, et al. Quality of life in patients with benign paroxysmal positional vertigo and/or Meniere’s disease. Rev Bras Otorinolaringol 2005;71:776–82
   Google Scholar
• Gamiz MJ, Lopez-Escamez JA. Health-related quality of life in patients over sixty years old with benign paroxysmal positional vertigo. Gerontology 2004;50:82–6
   PubMed Web of Science ®Google Scholar
• Yardley L, Dibb B, Osborne G. Factors associated with quality of life in Meniere’s disease. Clin Otolaryngol Allied Sci 2003;28:436–41
   PubMed Web of Science ®Google Scholar
• Kinney SE, Sandridge SA, Newman CW. Long-term effects of Meniere’s disease on hearing and quality of life. Am J Otol 1997;18:67–73
   Google Scholar
• Pravin D, Malhotra S, Chakrabarti S, et al. Frequency of major affective disorders in first-degree relatives of patients with type 2 diabetes mellitus. Indian J Med Res 2006;124:291–8
   PubMed Web of Science ®Google Scholar
• Fryers T, Melzer D, Jenkins R, et al. The distribution of the common mental disorders: social inequalities in Europe. Clin Pract Epidemiol Mental Health 2005;1:14
   PubMedGoogle Scholar
• Ayuso-Mateos JL, Vásquez-Barquero JL, Dowrick C, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001;179:308–16
   PubMed Web of Science ®Google Scholar
• Stankunas M, Kalediene R, Starkuviene S, et al. Duration of unemployment and depression: a cross-sectional survey in Lithuania. BMC Publ Health 2006;6:174
   PubMed Web of Science ®Google Scholar
• Gauthier S, Juby A, Morelli L, et al.; for the EXTEND Investigators. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND study. Curr Med Res Opin 2006;22:2251–65
   Google Scholar
• Saeed SR. Fortnightly review. Diagnosis and treatment of Ménière’s disease. Br Med J 1998;316:368–72
   Google Scholar